抗生物質ストレスを受けたミコバクテリアのダイナミックな持続性
Yuichi Wakamoto1, Neeraj Dhar, Remy Chait
1School of Life Sciences, Swiss Federal Institute of Technology in Lausanne (EPFL), 1015 Lausanne, Switzerland.
まとめ
Mycobacterium smegmatis persistersは,抗生物質治療中にダイナミックに分裂して死にます. 彼らの生存は,イソニアジド (INH) を活性化するカタラゼペロキシダース (KatG) のストキャスティックパルスに依存しています.
科学分野:
- 微生物学 微生物学とは
- バクテリアの生理学
- 抗生物質耐性菌は,抗生物質耐性菌として存在します.
背景:
- 抗生物質の治療は,しばしば,生き残った細菌細胞のわずかな部分を残します.
- 持続性細胞は,歴史的に分裂しないまたはゆっくり分裂する細胞であると考えられていた.
- バクテリアの持続性の根底にあるメカニズムは,まだ完全に理解されていません.
研究 の 目的:
- イソニアジド (INH) に曝露する間,Mycobacterium smegmatisの持続メカニズムを調査する.
- 持続性の細胞分裂と死亡ダイナミクスを特徴づけるために.
- INH誘発の持続性におけるカタラゼ-過酸化酵素 (KatG) の役割を調査する.
主な方法:
- マイクロ流体培養とタイムレプス顕微鏡を用いて,個々のMycobacterium smegmatis細胞を観察した.
- 定量化された細胞分裂,死亡率,およびカタラゼ-ペロキシダース (KatG) の遺伝子発現.
- KatG発現,細胞分裂,生存率の相関を分析した.
主要な成果:
- Mycobacterium smegmatis persistsが活発に分裂して死に,安定した集団サイズを維持しています.
- INHの活性化剤であるカタラゼペロキシダース (KatG) の発現は,ストキャスティックパルスで発生しました.
- 頻度の低いKatGパルシングは,細胞生存と負の相関関係があり,持続性における役割を示唆しています.
- 同胞細胞間の相関したKatGパルスと死は,潜在的な表遺伝的影響を示した.
結論:
- バクテリアの持続は,単に休眠状態ではなく,バランスのとれた細胞分裂と死を含むダイナミックなプロセスです.
- ストカスティックKatGの活性化は,INH治療中にMycobacterium smegmatisの生存に影響する.
- エピジェネティックメカニズムは,持続的な細胞の行動と抗生物質への適応を調節する役割を果たす可能性があります.
関連する概念動画
Defense Against Bacterial Pathogens
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Bacterial Phylum Actinobacteria
Coryneform bacteria are gram-positive, aerobic, nonmotile rods that exhibit irregular, club-shaped, or V-shaped arrangements. Their V-shape results from snapping division, where the inner cell wall layer forms the cross-wall, while the outer layer remains intact until it ruptures on one side, causing the daughter cells to bend away.The primary genera are Corynebacterium and Arthrobacter. Corynebacterium includes diverse species, ranging from saprophytes to pathogens like Corynebacterium...
Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...


